MedTrace Logo

The Impact of Genicular Nerves Chemical Neurolysis on the Quality of Life of Patients with Advanced Knee Osteoarthritis.

NCT06087601 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2025-01-21

No results posted yet for this study

Summary

Genicular nerves chemical neurolysis in advanced osteoarthritis of the knee joint.

Conditions

Interventions

DRUG

0.9% Sodium chloride

us-guided bilateral genicular nerves sham block with 0,5ml 0,9% normal saline

DRUG

95% ethanol

us-guided bilateral genicular nerves neurolysis with 0,5ml 95% ethanol

Sponsors & Collaborators

  • Poznan University of Medical Sciences

    lead OTHER

Principal Investigators

  • Katarzyna Wieczorowska-Tobis, Prof.dr hab · Poznań University of Medical Sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
110 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-17
Primary Completion
2025-01-10
Completion
2025-01-14

Countries

  • Poland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06087601 on ClinicalTrials.gov